Management of hematologic and infectious complications of intensive induction therapy for small cell carcinoma of the lung
- 1 May 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 74 (5) , 741-746
- https://doi.org/10.1016/0002-9343(83)91061-6
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Emergence of High-Level Trimethoprim Resistance in FecalEscherichia coliduring Oral Administration of Trimethoprim or Trimethoprim-SulfamethoxazoleNew England Journal of Medicine, 1982
- Failure of Oral Trimethoprim-Sulfamethoxazole Prophylaxis in Acute LeukemiaNew England Journal of Medicine, 1982
- Complications in the treatment of small cell carcinoma of the lungCancer Treatment Reviews, 1981
- Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patientsThe American Journal of Medicine, 1980
- The Use of Lithium Carbonate to Reduce Infection and Leukopenia during Systemic ChemotherapyNew England Journal of Medicine, 1980
- Duration of empiric antibiotic therapy in granulocytopenic patients with cancerThe American Journal of Medicine, 1979
- Elevated Platelet-Associated IgG in the Thrombocytopenia of SepticemiaNew England Journal of Medicine, 1979
- “Total” therapy for oat cell carcinoma of the lungInternational Journal of Radiation Oncology*Biology*Physics, 1977
- ANORECTAL DISEASE IN PATIENTS WITH NON-HÆMATOLOGICAL MALIGNANCYThe Lancet, 1976
- The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind StudyTransfusion, 1974